Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab

Guardado en:
Detalles Bibliográficos
Autores principales: Forero, Andres, Hamadani, Mehdi, Kipps, Thomas, Fanale, Michelle, Cuneo, Antonio, Perez de Oteyza, Jaime, Gladstone, Douglas, Andre, Marc, Bellam, Naresh, Goswami, Trishna, Ibrahim, Ramy, Schneider, Amy, Liang, Meina, Eck, Steven, Elgeioushi, Nairouz, Herbst, Ronald, Cheson, Bruce D
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3990958/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-1-S1-P43
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares